BRIEF-Palvella Therapeutics And Pieris Pharmaceuticals Announce Definitive Merger Agreement

Reuters

Jul 24, 2024

July 24 (Reuters) - Pieris Pharmaceuticals Inc :

* PALVELLA THERAPEUTICS AND PIERIS PHARMACEUTICALS ANNOUNCE DEFINITIVE MERGER AGREEMENT

* PIERIS PHARMACEUTICALS INC - TO ISSUE SHARES OF PIERIS COMMON STOCK TO PRE-MERGER PALVELLA STOCKHOLDERS AS MERGER CONSIDERATION

* PIERIS PHARMACEUTICALS INC - PALVELLA TO BECOME WHOLLY-OWNED UNIT OF CO

* PIERIS PHARMACEUTICALS - PRE-MERGER PIERIS STOCKHOLDERS WILL OWN ABOUT 18% OF COMBINED COMPANY

* PIERIS PHARMACEUTICALS - PRE-MERGER PALVELLA STOCKHOLDERS WILL OWN APPROXIMATELY 82% OF COMBINED COMPANY ON A PRO FORMA BASIS

* PIERIS PHARMACEUTICALS- COMBINED COMPANY TO BE LED BY WES KAUPINEN & OTHER MEMBERS OF PALVELLA MANAGEMENT TEAM

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2453207795"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2453207795\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2453207795?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-24 18:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2453207795","market":"us","top_or_hot":-1,"title":"BRIEF-Palvella Therapeutics And Pieris Pharmaceuticals Announce Definitive Merger Agreement","media":"Reuters","content":"<html><body><p>July 24 (Reuters) - Pieris Pharmaceuticals Inc   :</p><p>   * PALVELLA THERAPEUTICS AND PIERIS PHARMACEUTICALS ANNOUNCE DEFINITIVE MERGER AGREEMENT</p><p>   * PIERIS PHARMACEUTICALS INC - TO ISSUE SHARES OF PIERIS COMMON STOCK TO PRE-MERGER PALVELLA STOCKHOLDERS AS MERGER CONSIDERATION</p><p>   * PIERIS PHARMACEUTICALS INC - PALVELLA TO BECOME WHOLLY-OWNED UNIT OF CO</p><p>   * PIERIS PHARMACEUTICALS - PRE-MERGER PIERIS STOCKHOLDERS WILL OWN ABOUT 18% OF COMBINED COMPANY</p><p>   * PIERIS PHARMACEUTICALS - PRE-MERGER PALVELLA STOCKHOLDERS WILL OWN APPROXIMATELY 82% OF COMBINED COMPANY ON A PRO FORMA BASIS</p><p>   * PIERIS PHARMACEUTICALS- COMBINED COMPANY TO BE LED BY WES KAUPINEN &amp; OTHER MEMBERS OF PALVELLA MANAGEMENT TEAM</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Palvella Therapeutics And Pieris Pharmaceuticals Announce Definitive Merger Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Palvella Therapeutics And Pieris Pharmaceuticals Announce Definitive Merger Agreement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-07-24 18:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>July 24 (Reuters) - Pieris Pharmaceuticals Inc   :</p><p>   * PALVELLA THERAPEUTICS AND PIERIS PHARMACEUTICALS ANNOUNCE DEFINITIVE MERGER AGREEMENT</p><p>   * PIERIS PHARMACEUTICALS INC - TO ISSUE SHARES OF PIERIS COMMON STOCK TO PRE-MERGER PALVELLA STOCKHOLDERS AS MERGER CONSIDERATION</p><p>   * PIERIS PHARMACEUTICALS INC - PALVELLA TO BECOME WHOLLY-OWNED UNIT OF CO</p><p>   * PIERIS PHARMACEUTICALS - PRE-MERGER PIERIS STOCKHOLDERS WILL OWN ABOUT 18% OF COMBINED COMPANY</p><p>   * PIERIS PHARMACEUTICALS - PRE-MERGER PALVELLA STOCKHOLDERS WILL OWN APPROXIMATELY 82% OF COMBINED COMPANY ON A PRO FORMA BASIS</p><p>   * PIERIS PHARMACEUTICALS- COMBINED COMPANY TO BE LED BY WES KAUPINEN &amp; OTHER MEMBERS OF PALVELLA MANAGEMENT TEAM</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2453207795","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2453207795","pubTimestamp":1721818237,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 24  - Pieris Pharmaceuticals Inc   :   * PALVELLA THERAPEUTICS AND PIERIS PHARMACEUTICALS ANNOUNCE DEFINITIVE MERGER AGREEMENT   * PIERIS PHARMACEUTICALS INC - TO ISSUE SHARES OF PIERIS COMMON STOCK TO PRE-MERGER PALVELLA STOCKHOLDERS AS MERGER CONSIDERATION   * PIERIS PHARMACEUTICALS INC - PALVELLA TO BECOME WHOLLY-OWNED UNIT OF CO   * PIERIS PHARMACEUTICALS - PRE-MERGER PIERIS STOCKHOLDERS WILL OWN ABOUT 18% OF COMBINED COMPANY   * PIERIS PHARMACEUTICALS - PRE-MERGER PALVELLA STOCKHOLDERS WILL OWN APPROXIMATELY 82% OF COMBINED COMPANY ON A PRO FORMA BASIS   * PIERIS PHARMACEUTICALS- COMBINED COMPANY TO BE LED BY WES KAUPINEN & OTHER MEMBERS OF PALVELLA MANAGEMENT TEAMSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"简介-Palvella Therapeutics和Pieris Pharmaceuticals宣布最终合并协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"PIRS":1},"content_text":"July 24 (Reuters) - Pieris Pharmaceuticals Inc   :   * PALVELLA THERAPEUTICS AND PIERIS PHARMACEUTICALS ANNOUNCE DEFINITIVE MERGER AGREEMENT   * PIERIS PHARMACEUTICALS INC - TO ISSUE SHARES OF PIERIS COMMON STOCK TO PRE-MERGER PALVELLA STOCKHOLDERS AS MERGER CONSIDERATION   * PIERIS PHARMACEUTICALS INC - PALVELLA TO BECOME WHOLLY-OWNED UNIT OF CO   * PIERIS PHARMACEUTICALS - PRE-MERGER PIERIS STOCKHOLDERS WILL OWN ABOUT 18% OF COMBINED COMPANY   * PIERIS PHARMACEUTICALS - PRE-MERGER PALVELLA STOCKHOLDERS WILL OWN APPROXIMATELY 82% OF COMBINED COMPANY ON A PRO FORMA BASIS   * PIERIS PHARMACEUTICALS- COMBINED COMPANY TO BE LED BY WES KAUPINEN & OTHER MEMBERS OF PALVELLA MANAGEMENT TEAMSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}